loader

irritable bowel syndrome

LATEST ARTICLES
cannabis investing

AXIM Biotech Secures Funding for Trials and Studies

pharmaceutical investing

Concordia Announces RedHill Biopharma Began Promoting Donnatal

cannabis investing

Medical Marijuana Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome

medical device investing

Biomerica Announces Second Quarter Financial Results; Sales up Over 22% for the Quarter

AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum

AXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGum

AXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGum

AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms

Biomerica Announces Year End Results

Synergy Pharmaceuticals Provides Update on Ongoing FDA Review of Plecanatide CIC NDA and IBS-C Clinical Development Program

Synergy Pharmaceuticals Provides Update on Ongoing FDA Review of Plecanatide CIC NDA and IBS-C Clinical Development Program

Synergy Pharmaceuticals Provides Update on Ongoing FDA Review of Plecanatide CIC NDA and IBS-C Clinical Development Program

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES